Subscribe
shutterstock_2174132583_fizkes
fizkes / Shutterstock.com
29 June 2023Big PharmaLiz Hockley

US appeals court upholds decision on wrinkle treatment

Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
PTAB invalidates Medytox Botox patent
20 July 2021   The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Americas
Fed Circuit hands win to Galderma in Teva suit
30 January 2020   The US Court of Appeals for the Federal Circuit has revived patent infringement litigation brought against Teva by dermatological company Galderma, a former subsidiary of Nestlé Skin Health.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
PTAB invalidates Medytox Botox patent
20 July 2021   The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Americas
Fed Circuit hands win to Galderma in Teva suit
30 January 2020   The US Court of Appeals for the Federal Circuit has revived patent infringement litigation brought against Teva by dermatological company Galderma, a former subsidiary of Nestlé Skin Health.

More on this story

Big Pharma
PTAB invalidates Medytox Botox patent
20 July 2021   The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Americas
Fed Circuit hands win to Galderma in Teva suit
30 January 2020   The US Court of Appeals for the Federal Circuit has revived patent infringement litigation brought against Teva by dermatological company Galderma, a former subsidiary of Nestlé Skin Health.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility